Belsomra is expected to be available in late 2014 or early 2015. This is based on the assumption that the DEA will issue a final decision on the scheduling for Belsomra by this time, according to Merck spokeswoman Pamela Eisele. Earlier this year, the DEA proposed a schedule IV classification https://kevinl418cjp3.blogadvize.com/profile